206 related articles for article (PubMed ID: 28413638)
21. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
Mokrowiecka A; Gasiorowska A; Małecka-Panas E
Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
[TBL] [Abstract][Full Text] [Related]
22. [Diagnostic role of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in pediatric inflammatory bowel disease].
Kim JE; Kim KS; Seo JK
Korean J Gastroenterol; 2003 Oct; 42(4):297-302. PubMed ID: 14634349
[TBL] [Abstract][Full Text] [Related]
23. Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis.
Dendrinos KG; Becker JM; Stucchi AF; Saubermann LJ; LaMorte W; Farraye FA
J Gastrointest Surg; 2006; 10(7):1060-4. PubMed ID: 16843878
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
Reese GE; Constantinides VA; Simillis C; Darzi AW; Orchard TR; Fazio VW; Tekkis PP
Am J Gastroenterol; 2006 Oct; 101(10):2410-22. PubMed ID: 16952282
[TBL] [Abstract][Full Text] [Related]
25. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
[TBL] [Abstract][Full Text] [Related]
26. pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN.
Birimberg-Schwartz L; Wilson DC; Kolho KL; Karolewska-Bochenek K; Afzal NA; Spray C; Romano C; Lionetti P; Hauer AC; Martinez-Vinson C; Veres G; Escher JC; Turner D;
Inflamm Bowel Dis; 2016 Aug; 22(8):1908-14. PubMed ID: 27135480
[TBL] [Abstract][Full Text] [Related]
27. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease.
Mokrowiecka A; Gasiorowska A; Malecka-Panas E
Hepatogastroenterology; 2007; 54(77):1443-8. PubMed ID: 17708273
[TBL] [Abstract][Full Text] [Related]
28. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.
Targan SR; Landers CJ; Yang H; Lodes MJ; Cong Y; Papadakis KA; Vasiliauskas E; Elson CO; Hershberg RM
Gastroenterology; 2005 Jun; 128(7):2020-8. PubMed ID: 15940634
[TBL] [Abstract][Full Text] [Related]
29. Detection of a novel antigen for Crohn's disease.
Wei Y; Chen T; Yang W; Li H; Fang C; Liu Q; Chen Y; Mei Q
Scand J Gastroenterol; 2021 Dec; 56(12):1427-1433. PubMed ID: 34487462
[TBL] [Abstract][Full Text] [Related]
30. The value of serologic markers in indeterminate colitis: a prospective follow-up study.
Joossens S; Reinisch W; Vermeire S; Sendid B; Poulain D; Peeters M; Geboes K; Bossuyt X; Vandewalle P; Oberhuber G; Vogelsang H; Rutgeerts P; Colombel JF
Gastroenterology; 2002 May; 122(5):1242-7. PubMed ID: 11984510
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease.
Ruemmele FM; Targan SR; Levy G; Dubinsky M; Braun J; Seidman EG
Gastroenterology; 1998 Oct; 115(4):822-9. PubMed ID: 9753483
[TBL] [Abstract][Full Text] [Related]
32. Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease.
Amcoff K; Joossens M; Pierik MJ; Jonkers D; Bohr J; Joossens S; Romberg-Camps M; Nyhlin N; Wickbom A; Rutgeerts PJ; Tysk C; Bodin L; Colombel JF; Vermeire S; Halfvarson J
J Crohns Colitis; 2016 Jun; 10(6):695-702. PubMed ID: 26818662
[TBL] [Abstract][Full Text] [Related]
33. Targeting tissular immune response improves diagnostic performance of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease.
Bertin D; Grimaud JC; Lesavre N; Benelmouloud C; Desjeux A; Garcia S; Desplat-Jégo S
PLoS One; 2013; 8(11):e80433. PubMed ID: 24303014
[TBL] [Abstract][Full Text] [Related]
34. Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype.
Takaishi H; Kanai T; Nakazawa A; Sugata F; Nikai A; Yoshizawa S; Hamamoto Y; Funakoshi S; Yajima T; Iwao Y; Takemura M; Ozaki S; Hibi T
J Gastroenterol; 2012 Sep; 47(9):969-77. PubMed ID: 22644337
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases.
Saibeni S; Folli C; de Franchis R; Borsi G; Vecchi M
Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881
[TBL] [Abstract][Full Text] [Related]
36. Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in Children.
Spencer EA; Davis SM; Mack DR; Boyle BM; Griffiths AM; LeLeiko NS; Sauer CG; Keljo DJ; Markowitz JF; Baker SS; Rosh JR; Baldassano RN; Oliva-Hemker M; Pfefferkorn MD; Otley AR; Heyman MB; Noe JD; Patel AS; Rufo PA; ; Alison Marquis M; Walters TD; Collins MH; Kugathasan S; Denson LA; Hyams JS; Dubinsky MC
Inflamm Bowel Dis; 2018 May; 24(6):1335-1343. PubMed ID: 29718391
[TBL] [Abstract][Full Text] [Related]
37. Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease.
Solberg IC; Lygren I; Cvancarova M; Jahnsen J; Stray N; Sauar J; Schreiber S; Moum B; Vatn MH;
Inflamm Bowel Dis; 2009 Mar; 15(3):406-14. PubMed ID: 19009607
[TBL] [Abstract][Full Text] [Related]
38. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
[TBL] [Abstract][Full Text] [Related]
39. The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population.
O'Donnell S; O'Sullivan M; O'Morain CA; Ryan BM
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1464-9. PubMed ID: 24047859
[TBL] [Abstract][Full Text] [Related]
40. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.
Davis MK; Andres JM; Jolley CD; Novak DA; Haafiz AB; González-Peralta RP
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
